{
    "Trade/Device Name(s)": [
        "DiaSpect Tm system"
    ],
    "Submitter Information": "EKF-diagnostic GmbH",
    "510(k) Number": "K172173",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081719"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKR"
    ],
    "Summary Letter Date": "February 20, 2018",
    "Summary Letter Received Date": "March 05, 2018",
    "Submission Date": "July 10, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.5620"
    ],
    "Regulation Name(s)": [
        "Automated hemoglobin system"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "DiaSpect Tm analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Optical absorbance",
        "Spectrophotometry"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Cuvette",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSpect Tm system, an automated spectrophotometric analyzer for quantitative hemoglobin measurement in whole blood at point-of-care settings",
    "Indications for Use Summary": "Intended for in vitro quantitative measurement of total hemoglobin in non-anticoagulated capillary whole blood and venous whole blood collected in K2EDTA or lithium heparin tubes for point-of-care use",
    "fda_folder": "Hematology"
}